Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore effective ways to live frugally and build wealth. Smart choices can enhance your financial stability.
28,655 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
Wix faced a sharp stock drop after its quarterly results and cautious analyst notes. This article breaks down the fac...
What a difference a year makes. Last year, Wall Street questioned this AI stock’s valuation. Today, analysts anticipa...
Intel faces renewed pressure as AMD gains share in the server CPU market, driven by AI workloads. This guide explains...
When you weigh broad health exposure against a focused pharmaceutical bet, two ETFs stand out: IYH and PJP. This guid...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
The market mood says AI spending is peaking. But one company’s long-term orders hint at a different story. This guide...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
As volatility in Bitcoin keeps traders on edge, JPMorgan analysts argue that cash may be the stabilizer behind a bitc...
Two popular small etfs from ishares, IWO and ISCG, offer different paths into the fast-growing small-cap space. This ...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...